Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 7 NSCLC 2 Meningeal Carcinomatosis 2 Bronchial Neoplasms 2 Brain Neoplasms 2 Non-Small Cell Lung Cancer With EGFR T790M Mutation 1 Neurocognitive 1 Advanced Non-small Cell Lung Cancer 1

Interventions

osimertinib 1 abivertinib 1 Radiosurgery 1 Gefitinib 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Non-small Cell Lung Cancer × osimertinib × Clear all

NCT05489731 2023-06-15

VIC-1911

Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.

Phase 1 Unknown

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡